Exelixis, Inc. (EXEL)
42.20
+0.33
(+0.79%)
USD |
NASDAQ |
Dec 10, 09:46
Exelixis Total Assets (Quarterly): 2.824B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 601.14M |
| ADMA Biologics, Inc. | 568.69M |
| Aldeyra Therapeutics, Inc. | 77.80M |
| Merck & Co., Inc. | 129.55B |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 662.85M |
| Shareholders Equity (Quarterly) | 2.161B |
| Debt to Equity Ratio | 0.0817 |
| Current Ratio | 3.752 |
| Net Debt Paydown Yield | 0.04% |